Research Resources Workshop Wednesday - NJACTS – Support for Clinical/Translational Researchers Reynold A. Panettieri Jr., MD – RBHS Vice Chancellor for Translational Medicine and Science, RITMS

Center for COVID Response and Pandemic Preparedness (CCRP2) COVID-19 Seminar Series-Max Seibold, National Jewish Health.

Child Health Institute COVID Discussion-Short Talk on mRNA Vaccine Development, Lisa Denzin, Rutgers. Join via Webex.

Center for Cell Signaling Chalk Talk - “Prevent Oncogene Ablation Resistance in KRAS-addicted Cancers” Speaker: Pingping Hou, Ph.D., Department of Cell Biology, MD Cancer Center, The University of Texas Join via Zoom. Meeting ID: 947 6491 0684 Password: 750269

CINJ Recruitment Lecture - “Reconstructing the Molecular Life History of Glioma” Speaker: Floris Barthel, MD Postdoctoral Associate The Jackson Laboratory for Genomic Medicine Join via Webex. Meeting number (access code): 120 592 6796 Meeting password: mbPuxqDn457

Saving Lives with the COVID-19 Vaccine in NJ Latinx Communities - The New Jersey Department of Health (NJDOH) is hosting a virtual town hall series. From the NJDOH event website: Nearly a year into the pandemic, COVID-19 continues to circulate in our state and nation. Vaccination is a crucial component in battling the virus, especially in […]

CINJ Cancer Pharmacology Research Program – “Data-driven protein engineering for developing smart therapeutic enzymes” Speaker: Sagar D. Khare, PhD, Associate professor, Chemistry and Chemical Biology & Institute for Quotative Biomedicine. To receive meeting login information, please pre-register here

NJ ACTS Special Populations Core Webinar Series-Modeling COVID-19 Dynamics and Patterns Across New Jersey: Assessing Effects of Heterogeneities, Exposure Controls and Social and Environmental Factors,  Panos G. Georgopoulos, Rutgers. Connect via Zoom. View Flyer.

Rutgers Princeton Center for Computational Cognitive Neuropsychiatry Seminar-Stephanie Groman

CINJ Grand Rounds - “NOS2 and COX2 as Major Drivers of Poor Outcomes in ER – Breast Cancer. New Therapeutic Opportunities in a Difficult Disease” Speaker: David Wink, PhD, AAS Fellow; Deputy Director for Translational Sciences, Cancer Inflamation Program, National Cancer Institute Pre-registration is required. Register here